MBRX
Moleculin Biotech Inc
Halal Rating :
Last Price
$1.88
Last updated:
Market Cap
-
7D Change
13.94%
1 Year Change
274.28%
Company Overview
Industries
Exchange
Next Earnings Date
Moleculin Biotech Inc is a clinical-stage pharmaceutical company focused on the development of innovative cancer treatments. The company specializes in developing drugs for highly resistant tumors and cancers. Their primary drug candidates include Annamycin for the treatment of relapsed or refractory acute myeloid leukemia (AML), WP1066 for brain tumors, and WP1122 for treating various types of cancers.
Use of Interest
| Reporting Date | Total Revenue | Total Operating Expense | Interest Income | Interest Expense | Interest Income Ratio | Interest Expense Ratio |
|---|
Company Impact
Help us evaluate Moleculin Biotech Inc's impact from a halal perspective. Vote on the most significant aspect and submit any considerations that we may have missed.